Oral bisphosphonates and chronic kidney disease: progression and safety (OSTEOPOROSIS INTERNATIONAL, 2018)

(untitled) - Prieto-Alhambra, D; Robinson, D; Strauss, V; Ali, S; Pallares, N; Tebe, C; Cooper, C; Abrahamsen, B; Caskey, F; Ben-Shlomo, Y; Judge, A; Javaid, K; et al.